McKesson stock extends CVS pact through 2032 with guidance intact

Published on 10/04/2026 at 20:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock carries fiscal 2027 adjusted EPS guidance of USD 44.20-45.00 after the October 1 CVS pact. Quarterly revenue reached USD 105.38 billion.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen — Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) closed at USD 902.28 on the NYSE on October 2, 2026, up 0.38 percent from the prior session. The key company development arrived on October 1, when Business Wire reported that McKesson had signed an agreement in principle to continue supplying CVS Health pharmacies and distribution centers through June 2032.

CVS agreement secures visibility

The pact covers mail-order and specialty pharmacies, retail pharmacies, and distribution centers. The companies have worked together for more than 25 years, but the arrangement remains subject to a definitive contract, leaving execution as the central condition for the expected continuity.

Business Wire said McKesson reaffirmed fiscal 2027 adjusted EPS guidance of USD 44.20-45.00 on October 1, 2026. Management also maintained its long-term adjusted EPS growth target at 13%-16%, putting the contract announcement alongside a stable earnings framework.

Quarterly figures set the baseline

The latest reported quarter produced revenue of USD 105.38 billion, up 7.7 percent year over year, while quarterly EPS reached USD 9.93 and exceeded consensus by USD 0.37, according to MarketBeat in its October 1, 2026 report. The revenue increase gives the long-term guidance a recent operating reference, while the EPS comparison shows that the quarter outperformed the published consensus by 3.9 percent.

The next earnings update is scheduled for November 4, 2026. Business Wire said the fiscal 2027 second-quarter results will be released after market close, followed by a 4:30 p.m. ET conference call.

Stock remains below yearly high

McKesson stock ended the October 2 session at USD 902.28, compared with a 52-week high of USD 999.00 and a low of USD 723.68. The close was 9.7 percent below the high, while market capitalization stood at USD 105.2 billion and trading volume reached 777,048 shares.